Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models
Stella Nyamoya, Patrizia Leopold, Birte Becker, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 1109-1123
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Regulation and signaling of the GPR17 receptor in oligodendroglial cells
Davide Lecca, Stefano Raffaele, Maria P. Abbracchio, et al.
Glia (2020) Vol. 68, Iss. 10, pp. 1957-1967
Closed Access | Times Cited: 46
Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model
Anna Nellessen, Stella Nyamoya, Adib Zendedel, et al.
Metabolic Brain Disease (2019) Vol. 35, Iss. 2, pp. 353-362
Closed Access | Times Cited: 41
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models
Anne Nack, Matthias Brendel, Julia Nedelcu, et al.
Cells (2019) Vol. 8, Iss. 2, pp. 94-94
Open Access | Times Cited: 40
Myelin Repair: From Animal Models to Humans
Myriam Cayre, Marie Falque, Océane Mercier, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32
Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis
Mahdad Abdi, Parichehr Pasbakhsh, Maryam Shabani, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1732-1746
Closed Access | Times Cited: 30
Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
Leo Heinig, Markus Kipp
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16093-16093
Open Access | Times Cited: 19
The committed oligodendrocyte precursor cell, a newly‐defined intermediate progenitor cell type in oligodendroglial lineage
Minxi Fang, Lixia Chen, Tao Tang, et al.
Glia (2023) Vol. 71, Iss. 11, pp. 2499-2510
Closed Access | Times Cited: 11
Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage
Yang Wang, Zhe Yu, Menghan Cheng, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118126-118126
Closed Access | Times Cited: 4
Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice
Yusheng Liang, Xu kang, Haiwang Zhang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: A review
Mohaddeseh Sadat Alavi, Gholamreza Karimi, Ali Roohbakhsh
Life Sciences (2019) Vol. 224, pp. 33-40
Closed Access | Times Cited: 25
Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1–42 through Nrf2/HO-1 and NF-κB signaling pathway in mice
Shiyu Jin, Xin Wang, XiaoTong Xiang, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108335-108335
Closed Access | Times Cited: 19
Macroglial diversity: white and grey areas and relevance to remyelination
Inge L. Werkman, Dennis H. Lentferink, Wia Baron
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 1, pp. 143-171
Open Access | Times Cited: 20
Aquaporin-4 Expression during Toxic and Autoimmune Demyelination
Sven Olaf Rohr, Theresa Greiner, Sarah Joost, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2187-2187
Open Access | Times Cited: 19
Metabolomic and transcriptomic signatures of prenatal excessive methionine support nature rather than nurture in schizophrenia pathogenesis
Siwei Chen, Wedad Alhassen, Ryan F. Yoshimura, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells
Davide Marangon, Matteo Audano, Silvia Pedretti, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2369-2369
Open Access | Times Cited: 10
Laquinimod Supports Remyelination in Non-Supportive Environments
Stella Nyamoya, Julia Steinle, Uta Chrzanowski, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1363-1363
Open Access | Times Cited: 16
Identification and characterization of select oxysterols as ligands for GPR17
Anthony Harrington, Changlu Liu, Naomi Phillips, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 4, pp. 401-421
Open Access | Times Cited: 9
Animal Weight Is an Important Variable for Reliable Cuprizone-Induced Demyelination
Patrizia Leopold, Christoph Schmitz, Markus Kipp
Journal of Molecular Neuroscience (2019) Vol. 68, Iss. 4, pp. 522-528
Closed Access | Times Cited: 15
GPR17 receptor modulators and their therapeutic implications: review of recent patents
Gabriella Marucci, Diego Dal Ben, Catia Lambertucci, et al.
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 2, pp. 85-95
Open Access | Times Cited: 14
Laquinimod ameliorates secondary brain inflammation
Julia Nedelcu, Christin Reinbach, Philipp Riedler, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104675-104675
Open Access | Times Cited: 13
Discovery of Anthranilic Acid Derivatives as Antagonists of the Pro-Inflammatory Orphan G Protein-Coupled Receptor GPR17
Nader M. Boshta, Michael Lewash, Meryem Köse, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19365-19394
Closed Access | Times Cited: 1
Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases
Samuel Morales-Navarro, Luis Prent-Peñaloza, Yeray A. Rodríguez‐Núñez, et al.
Processes (2019) Vol. 7, Iss. 12, pp. 940-940
Open Access | Times Cited: 10
Cuprizone as a model of myelin and axonal damage
Stella Nyamoya, Felix Schweiger, Markus Kipp, et al.
Drug Discovery Today Disease Models (2017) Vol. 25-26, pp. 63-68
Closed Access | Times Cited: 7
Inhibition of GPR17 with pranlukast protects against TNF-α-induced loss of type II collagen in ATDC5 cells
Zhangfu Wang, Weiwei Zhou, Guangbin Zheng, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106870-106870
Closed Access | Times Cited: 6
Analysis of the GPR17 receptor in NG2‐glia under physiological conditions unravels a new subset of oligodendrocyte progenitor cells with distinct functions
Antonio J. Miralles, Nicole Unger, Nirmal Kannaiyan, et al.
Glia (2023) Vol. 71, Iss. 6, pp. 1536-1552
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top